Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes
- PMID: 7119438
Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes
Abstract
The relationship between clinical activity of systemic lupus erythematosus (SLE) and molecular sizes of DNA fragments isolated from DNA/anti-DNA antibody immune complexes were examined. Among sera from twenty-eight patients with SLE examined, three different molecular sizes of DNA were identified, namely, DNA of m.v. 25,000 with 30 to 50 base pairs (bp); m.w. 100,000 with 150 to 200 bp; and m.w. 200,000 with 300 bp. On the basis of the molecular sizes of DNA fragments, we can divide patients with SLE into four groups. The first group contained DNA predominantly of m.w. 25,000. The second group contained DNA predominantly of m.w. 100,000. The third group contained DNA of m.w. 200,000. The fourth group contained both m.w. 25,000 and 100,000. A method to quantitate the amounts of DNA in DNA/anti-DNA immune complexes was developed. The amount of DNA fragments was estimated by measuring the amount of 32P-phosphate incorporated into 5 ends of DNA. Patients with severe disease tended to have greater amounts of DNA (up to 400 ng/ml serum). Two serial studies also support this result. Thus, the quantitative analysis shows that the amount of DNA in the immune complexes is highly correlated with disease activity (r = 0.864; p less than 0.001). These results suggest that DNA/anti-DNA immune complexes may play some role in the pathogenesis of lupus nephritis.
Similar articles
-
DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.Clin Exp Immunol. 1981 Mar;43(3):605-14. Clin Exp Immunol. 1981. PMID: 6974627 Free PMC article.
-
Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.Q J Med. 1983 Autumn;52(208):471-87. Q J Med. 1983. PMID: 6606818
-
Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.J Clin Invest. 1970 Nov;49(11):2106-18. doi: 10.1172/JCI106428. J Clin Invest. 1970. PMID: 4097660 Free PMC article.
-
Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.Allerg Immunol (Leipz). 1984;30(1):3-13. Allerg Immunol (Leipz). 1984. PMID: 6233860 Review.
-
Immune complexes in SLE.Clin Rheum Dis. 1982 Apr;8(1):49-62. Clin Rheum Dis. 1982. PMID: 6214365 Review. No abstract available.
Cited by
-
Serum levels of interferons in patients with systemic lupus erythematosus.Clin Exp Immunol. 1987 Dec;70(3):562-9. Clin Exp Immunol. 1987. PMID: 2449306 Free PMC article.
-
DNA-anti-DNA immune complexes. Antibody protection of a discrete DNA fragment from DNase digestion in vitro.J Clin Invest. 1984 Jul;74(1):185-90. doi: 10.1172/JCI111400. J Clin Invest. 1984. PMID: 6234327 Free PMC article.
-
Characterization of DNA in polyethylene glycol precipitated immune complexes from sera of patients with systemic lupus erythematosus.Clin Exp Immunol. 1983 Oct;54(1):169-77. Clin Exp Immunol. 1983. PMID: 6616966 Free PMC article.
-
Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations.Ann Rheum Dis. 1992 Jun;51(6):717-9. doi: 10.1136/ard.51.6.717. Ann Rheum Dis. 1992. PMID: 1616352 Free PMC article.
-
Anti-DNA antibodies--quintessential biomarkers of SLE.Nat Rev Rheumatol. 2016 Feb;12(2):102-10. doi: 10.1038/nrrheum.2015.151. Epub 2015 Nov 19. Nat Rev Rheumatol. 2016. PMID: 26581343 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical